Efficacy, safety and prognostic factors in patients with refractory metastatic colorectal cancer treated with trifluridine/tipiracil plus bevacizumab in a real-world setting
- Martínez-Lago, N.
- Chucla, T.C.
- De Castro, B.A.
- Ponte, R.V.
- Rendo, C.R.
- Rodriguez, M.I.G.-R.
- Diaz, S.S.
- Suarez, B.G.
- de la Cámara Gomez, J.
- Fernández, F.B.
- Salvador, M.M.
- Lopez, M.R.
Revista:
Scientific Reports
ISSN: 2045-2322
Ano de publicación: 2022
Volume: 12
Número: 1
Tipo: Artigo